Healio

FDA approves Trutakna for proteinuria reduction in IgA nephropathy

The FDA granted accelerated approval to atacicept-vymj for proteinuria reduction in adults with primary immunoglobulin A ...
The American Journal of Managed Care

INCA033989 Shows Potential as a Targeted Approach for Myelofibrosis With Mutant Calreticulin: Claire Harrison, MD

Harrison noted that responses were observed across calreticulin mutation types and among patients with additional mutations, with minimal toxicity reported to date. She concluded by describing ...
Fierce Biotech

MeiraGTx scores $400M from Oberland Capital to help get 2 gene therapies to commercialization

MeiraGTx has secured an investment of up to $400 million from Oberland Capital to help get its late-stage gene therapies | As ...

There's a right way to use an inhaler. What experts recommend

Inhalers are often used for asthma, a condition in which the lungs struggle to get enough air absorbed and sent to the body.

Hannah Berner Reveals That She Can't Smile After Getting Injectable in Masseter Muscles for TMJ

Hannah Berner revealed an unexpected result after getting Dysport, a form of injectable neurotoxin, in her masseter muscles ...

Ozempic vs Wegovy vs Mounjaro: What South Africans need to know about the weight-loss injections

Confused about Ozempic, Wegovy and Mounjaro? Here's what South Africans need to know about these prescription weight-loss ...
IFLScience

The FDA Just Cleared A New Species Of Flesh-Eating Maggot For Medical Use

Gross? Maybe, but they are highly effective.
The New Yorker

Why Are People Injecting Themselves with Peptides?

About a decade ago, a group of competitive CrossFitters in Charleston, South Carolina, went looking for ways to improve their athletic performance without taking steroids. At the time, members of the ...
Business Wire

Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)

SEOUL, South Korea--(BUSINESS WIRE)--Genexine (KQ 095700, CEO Sungjune Hong), a publicly-listed clinical-staged Korean biopharmaceutical company committed to the discovery and development of novel ...